Amplia Therapeutics CEO outlines 2023 milestones

News Direct

Mon, Jan 30, 2023, 4:00 PM1 min read

In this article:

Melbourne, Victoria --News Direct-- Amplia Therapeutics Ltd

Amplia Therapeutics Ltd (ASX:ATX) CEO Dr Chris Burns speaks with Proactive following his move into the leadership role late last year. Amplia is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in cancer and Amplia has a particular development focus in fibrotic tumours such as pancreatic and ovarian cancers.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

jonathan@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/amplia-therapeutics-ceo-outlines-2023-milestones-938374502

Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead
There's a much more popular AI stock on Capitol Hill than the leading AI chip maker.
Motley Fool•23h ago
Fed's Powell, jobs report and Apple will rock markets this week
In addition to economic and earnings news, inflation and geopolitical worries will have roles to play.
TheStreet•2h ago
Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves
The $50 million purchase could turn into Nvidia's biggest investment.
Motley Fool•18h ago
Trump to set interest rates himself under secret presidential plan
Donald Trump’s aides have drawn up secret plans to oust the chairman of the Federal Reserve and allow the president to set interest rates, according to reports.
The Telegraph•2d ago
Generative AI Software Sales Could Soar 6,260%: My Pick for the Best AI Stock to Buy Now (Hint: Not Nvidia)
This little-known software stock could soar as businesses spend more on generative artificial intelligence.
Motley Fool•23h ago
California Fast-Food Chains Are Now Serving Sticker Shock
A month after a higher state minimum wage for fast-food workers went into effect, consumers picking up burgers and burritos at chains in the Golden State grapple with prices rising at a faster clip than in other states.
The Wall Street Journal•3h ago
2 Incredibly Cheap Dividend Stocks to Buy Now
These two dividend payers have historically high yields and attractive businesses, even though there are some headwinds to deal with.
Motley Fool•10h ago
Tesla and Microsoft presented 2 distinct versions of AI. Investors liked both.
Earnings presentations from four of the biggest tech companies in the world showed two very different visions of AI: the moonshot and the incremental gains.
Yahoo Finance•19h ago
My late aunt gave her husband a life tenancy in her home — but her attorney won’t even let us see the will. Is this a bad sign?
“When she died, we were told by her attorney that we were responsible for the taxes and property insurance during the time when the life tennant lives in the home.”
MarketWatch•10h ago
In 4 Days, Philip Morris Stock Becomes an Even Better Investment
The tobacco giant will soon be allowed to sell a proven product in a proven market.
Motley Fool•11h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Amplia Therapeutics CEO outlines 2023 milestones

Contact Details

Recommended Stories

Forget Nvidia: Members of Congress Are Scooping Up Shares of Its Core Rival Instead

Fed's Powell, jobs report and Apple will rock markets this week

Nvidia Owns a 3.4% Stake in This Innovative Artificial Intelligence (AI) Stock Cathie Wood Loves

Trump to set interest rates himself under secret presidential plan

Generative AI Software Sales Could Soar 6,260%: My Pick for the Best AI Stock to Buy Now (Hint: Not Nvidia)

California Fast-Food Chains Are Now Serving Sticker Shock

2 Incredibly Cheap Dividend Stocks to Buy Now

Tesla and Microsoft presented 2 distinct versions of AI. Investors liked both.

My late aunt gave her husband a life tenancy in her home — but her attorney won’t even let us see the will. Is this a bad sign?

In 4 Days, Philip Morris Stock Becomes an Even Better Investment